Standard Chemical & Pharmaceutical Co. Ltd. - Taiwan
2nd Quarter ended June 30:
Figures in New Taiwan dollars.
2026 2025
Revenue NT$1,872,587,000 NT$1,827,915,000
Pretax Profit NT$436,097,000 NT$286,054,000
Net Profit NT$361,495,000 NT$252,440,000
Earnings Per Share
Basic 1.32 1.00
Diluted 1.31 1.00
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。